Integrin signaling links protein kinase Cε to the protein kinase B/Akt survival pathway in recurrent prostate cancer cells

Oncogene

Volumn 23, Issue 53, 2004, Pages 8659-8672

  Wu, Daqing ^a   Thakore, Chittam U ^a   Wescott, Ginger G ^a   McCubrey, James A ^a   Terrian, David M ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

catenin; Fibronectin; Integrin linked kinase; PI3K; Src kinase

Indexed keywords

BETA1 INTEGRIN; EPITOPE; FIBRONECTIN; INTEGRIN; INTEGRIN LINKED KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN KINASE C EPSILON; PROTEIN TYROSINE KINASE;

ACTIN FILAMENT; ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL SURVIVAL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

BETA CATENIN; CELL ADHESION; CELL LINE, TUMOR; CELL SURVIVAL; CYTOSKELETAL PROTEINS; EXTRACELLULAR MATRIX; FIBRONECTINS; HUMANS; INTEGRINS; MALE; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN KINASE C; PROTEIN KINASE C-EPSILON; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS;

EID: 9644259240     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207900     Document Type: Article

References (71)

1. Alessi DR. (2001). Biochem. Soc. Trans., 29, 1-14.
2. Arias-Salgado EG, Lizano S, Sarkar S, Brugge JS, Ginsberg MH and Shattil SJ. (2003). Proc. Natl. Acad. Sci. USA, 100, 13298-13302.
3. Bazzoni G, Ma L, Blue M and Hemler ME. (1998). J. Biol. Chem., 273, 6670-6678.
4. Beglova N, Blacklow SC, Takagi J and Springer TA. (2002). Nat. Struct. Biol., 9, 282-287.
5. Bernard D, Pourtier-Manzanedo A, Gil J and Beach D. (2003). J. Clin. Invest., 112, 1724-1731.
6. Berrier AL, Mastrangelo AM, Downward J, Ginsberg M and LaFlamme SE. (2000). J. Cell Biol., 151, 1549-1560.
7. Besson A, Wilson TL and Wee-Yong V. (2002). J. Biol. Chem., 277, 22073-22084.
8. Cenni V, Doppler H, Sonnenburg ED, Maraldi N, Newton AC and Toker A. (2002). Biochem. J., 363, 537-545.
9. Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, Franklin RA and McCubrey JA. (2003). Leukemia, 17, 590-603.
10. Chen S, Song CS, Lavvrovsky Y, Bi B, Vellanoweth R, Chatterjee B and Roy AK. (1998). Mol. Endocrinol., 12, 1558-1566.
11. Chesire DR, Ewing CM, Gage WR and Isaacs WB. (2002). Oncogens, 21, 2679-2694.
12. Chesire DR and Isaacs WB. (2002). Oncogene, 21, 8453-8469.
13. Chun JS, Ha MJ and Jacobson BS. (1996). J. Biol. Chem., 271, 13008-13012.
14. Cornford P, Evans J, Dodson A, Parsons K, Woolfenden A, Neoptolemos J and Foster CS. (1999). Am. J. Pathol., 154, 137-144.
15. Culig Z, Klocker H, Bartsch G, Steiner H and Hobisch A. (2003). J. Urol., 170, 1363-1369.
16. De La Taille A, Rubin MA, Chen MW, Vacherot F, De Medina SG, Burchardt M, Buttyan R and Chopin D. (2003). Clin. Cancer Res., 9, 1801-1807.
17. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J and Dedhar S. (1998). Proc. Natl. Acad. Sci. USA, 95, 11211-11216.
18. Diehl JA, Cheng M, Roussel MF and Sherr CJ. (1998). Genes Dev., 12, 3499-3511.
19. Dignam JD, Lebovitz RM and Roeder RG. (1983). Nucleic Acids Res., 11, 1475-1489.
20. Drobnjak M, Osman I, Scher HI, Fazzari M and Cordon-Cardo C. (2000). Clin. Cancer Res., 6, 1891-1895.
21. Eder IE, Culig Z, Ramoner R, Thurnher M, Putz T, Nessler-Menardi C, Tiefenthaler M, Bartsch G and Klocker H. (2000). Cancer Gene Ther., 7, 997-1007.
22. Eder IE, Hoffmann J, Rogatsch H, Schafer G, Zopf D, Bartsch G and Klocker H. (2002). Cancer Gene Ther., 9, 117-125.
23. Feldman BJ and Feldman D. (2001). Nat. Rev. Cancer, 1, 34-45.
24. Fonaro M, Manes T and Languino LR. (2001). Cancer Metast. Rev., 20, 321-331.
25. Fornaro M, Plescia J, Cheang S, Tallini G, King M, Altieri DC and Languino LR. (2003). J. Biol. Chem., 278, 50402-0411.
26. Futreal PA, Coin L, Marshall M, Down T, Hubbard R, Wooster R, Rahman N and Stratton MR. (2004). Nat. Rev., 4, 177-183.
27. Gounari F, Signoretti S, Bronson R, Klein L, Sellers WR, Kum J, Siermann A, Taketo MM, von Boehmer HM and Khazaie K. (2002). Oncogene, 21, 4099-4107.
28. Graff JR. (2002). Expert Opin. Ther. Targets, 6, 103-113.
29. Gregory CW, Johnson Jr RT, Mohler JL, French FS and Wilson EM. (2001). Cancer Res., 61, 2892-2898.
30. Hecht A and Kemler R. (2000). EMBO Rep., 1, 24-28.
31. Hermanto U, Zong CS, Li W and Wang LH. (2002). Mol. Cell. Biol., 22, 2345-2365.
32. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW. (1998). Science, 281, 1509-1512.
33. Hynes RO. (2002). Cell, 110, 673-687.
34. Ivaska J, Bosca L and Parker PJ. (2003). Nat. Cell Biol., 5, 363-369.
35. Ivaska J, Whelan RDH, Watson R and Parker PJ. (2002). EMBO J., 21, 3608-3619.
36. Korin R, Meir DB, Langzam L, Dekel Y, Konichezky M, Baniel J, Livne PM, Gal R and Sampson SR. (2004). Oncol. Rep., 11, 321-326.
37. Lee JW and Juliano RL. (2002). Biochim. Biophys. Acta, 1542, 23-31.
38. Liao Y, Grobholz R, Abel U, Trojan L, Michel MS, Angel P and Mayer D. (2003). Int. J. Cancer, 107, 676-680.
39. Linja MJ, Savinainen KJ, Saramaki OR, Tammela TLJ, Vessella RI and Visakorpu T. (2001). Cancer Res., 61, 3550-3555.
40. Litvinov IV, De Marzo AM and Isaacs JT. (2003). J. Clin. Endocrinol. Metab., 88, 2972-2982.
41. Mackay HJ and Twelves CJ. (2003). Endocr. Relat. Cancer, 10, 389-396.
42. Majumder PK, Yeh JJ, George DJ, Febbo PG, Kum J, Xue Q, Bikoff R, Ma H, Kantoff PW, Golub TR, Loda M and Sellers WR. (2003). Proc. Natl. Acad. Sci. USA, 100, 7841-7846.
43. McJilton MA, Sikes CV, Wescott GG, Wu D, Foreman TL, Gregory CW, Weidner DA, Ford OH, Lasater AM, Mohler JL and Terrian DM. (2003). Oncogene, 22, 6014-6024.
44. McMenamin ME, Soung P, Perera S, Kaplan I, Loda M and Sellers WR. (1999). Cancer Res., 59, 4291-4296.
45. Meuillet EJ, Mahadevan D, Vankayalapati H, Berggren M, Williams R, Coon A, Kozikowski AP and Powis G. (2003). Mol. Cancer Ther., 2, 389-399.
46. Moro L, Perlino E, Marra E, Languino LR and Greco M. (2004). J. Biol. Chem., 279, 1692-1702.
47. Mousses S, Wagner U, Chen Y, Kim JW, Bubendorf L, Bittner M, Pretlow T, Elkahloun AG, Trepel JB and Kallioniemi O-P. (2001). Oncogene, 20, 6718-6723.
48. Murillo H, Huang H, Schmidt LJ, Smith DI and Tindall DJ. (2001). Endocrinology, 142, 4795-4805.
49. Ng T, Shima D, Squire A, Bastiaens PIH, Gschmeissner S, Humphries MJ and Parker PJ. (1999). EMBO J., 18, 3909-3923.
50. Orchard S. (2002). Curr. Opin. Drug Discov. Dev., 5, 713-717.
51. Pankov R, Cukierman E, Clark K, Matsumoto K, Hahn C, Poulin B and Yamada KM. (2003). J. Biol. Chem., 278, 18671-18681.
52. Parekh DB, Katso RM, Leslie NR, Downes CP, Procyk KJ, Waterfield MD and Parker PJ. (2000). Biochem. J., 352, 425-433.
53. Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J and Dedhar S. (2000). Proc. Natl. Acad. Sci. USA, 97, 33207-33212.
54. Persad S, Troussard AA, McPhee TR, Mulholland DJ and Dedhar S. (2001). J. Cell Biol., 153, 1161-1174.
55. Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE and Parsons R. (1999). Proc. Natl. Acad. Sci. USA, 96, 1563-1568.
56. Schaller MD, Hildebrand JD, Shannon JD, Fox JW, Vines RR and Parsons JT. (1994). Mol. Cell. Biol., 14, 1680-1688.
57. Sharma M, Chuang WW and Sun Z. (2002). J. Biol. Chem., 277, 30935-30941.
58. Song LN, Herrell R, Byers S, Shah S, Wilson EM and Gelmann EP. (2003). Mol. Cell. Biol., 23, 1674-1687.
59. Tanaka Y, Gavrielides MV, Mitsuuchi Y, Fujii T and Kazanietz MG. (2003). J. Biol. Chem., 278, 33753-33762.
60. Tetsu O and McCormick F. (1999). Nature, 398, 422-426.
61. Tucker GC. (2002). Curr. Opin. Pharm., 2, 394-402.
62. van Bokhoven A, Varella-Garcia M, Korch C, Johannes WU, Smith EE, Miller HL, Nordeen SK, Miller GJ and Lucia MS. (2003). Prostate, 57, 205-225.
63. van Weeren PC, de Bruyn KM, de Vries-Smits AM, van Lint J and Burgering BM. (1998). J. Biol. Chem., 273, 13150-13156.
64. Wescott GG, Manring CM and Terrian DM. (1998). Methods Mol. Med., 22, 125-132.
65. Wong AS and Gumbiner BM. (2003). J. Cell Biol., 161, 1191-1203.
66. Wu D, Foreman TL, Gregory CW, McJilton MA, Wescott GG, Ford OH, Alvey RF, Mohler JL and Terrian DM. (2002). Cancer Res., 62, 2423-2429.
67. Wu D and Terrian DM. (2002). J. Biol. Chem., 277, 40449-40455.
68. Wu D, Wescott GG and Terrian DM. (2003). Methods Mol. Biol., 218, 143-153.
69. Xie Z, Zeng X, Waldman T and Glazer RI. (2003). Cancer Res., 63, 5370-5375.
70. Yoganathan TN, Costello P, Chen X, Jabali M, Yan J, Leung D, Zhang Z, Yee A, Dedhar S and Sanghera J. (2000). Biochem. Pharmacol., 60, 1115-1119.
71. Zegarra-Moro OL, Schmidt LJ, Huang H and Tindall DJ. (2002). Cancer Res., 62, 1008-1013.